BCRX
BCRX
NASDAQ · Biotechnology

Biocryst Pharmaceuticals Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.62
-0.28 (-3.15%)
As of May 10, 10:07 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +667.1% upside
Low Target $46.17
Average Target $66.12
High Target $78.89
Current Price $8.62
Current
$8.62
Target
$66.12
$46.17 $66.12 avg $78.89
Scenario Analysis
Bear Case
$46.17
435.6%
Low target
Base Case
$66.12
+667.1%
Avg target
Bull Case
$78.89
+815.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$11.31
-23.8% from high
52-Week Low
$6.00
+43.7% from low
Target vs 52W High
$66.12
+484.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%